Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：296
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [31] The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
    Jiang, Wenxiao
    Pan, Shuya
    Chen, Xin
    Wang, Zhi-wei
    Zhu, Xueqiong
    MOLECULAR CANCER, 2021, 20 (01)
  • [32] Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
    Kim, Joseph W.
    Eder, Joseph Paul
    ONCOLOGY-NEW YORK, 2014, 28 : 15 - 28
  • [33] Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer
    Noguchi, Emi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 321 - 332
  • [34] New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
    Villanueva, Nicolas
    Bazhenova, Lyudmila
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [35] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [37] The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
    Setordzi, Patience
    Chang, Xing
    Liu, Zi
    Wu, Yingliang
    Zuo, Daiying
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 895
  • [38] PD-1/PD-L1 blockade in renal cell cancer
    Beckermann, Kathryn E.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 77 - 84
  • [39] Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy
    Zhulai, Galina
    Oleinik, Eugenia
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
  • [40] Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer
    Alkholifi, Faisal K.
    Alsaffar, Rana M.
    MEDICINA-LITHUANIA, 2022, 58 (11):
12345